Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
AssigneeAllergan, Inc.
InventorsGurpreet Ahluwalia, Frederick C. Beddingfield, Sydney G. Edwards, Scott M. Whitcup
Life of this patent
Estimating the term…
Abstract
The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
Claims17
1) A method of growing eyelashes in chemotherapy patients, the method comprising applying 0.03% w/v bimatoprost to the eyelids before, during, or after chemotherapeutic treatment.
13) A method of preventing loss of eyelashes in patients undergoing chemotherapy, the method comprising applying 0.03% w/v bimatoprost to the eyelids before, during, or after chemotherapeutic treatment.
14) The method of claim 14, wherein the 0.03% bimatoprost is applied at least once a day.
Dependencies are inferred from the claim text.